Dermapharm Holding Correlations
| DMP Stock | 37.80 0.20 0.53% |
The current 90-days correlation between Dermapharm Holding and LIVZON PHARMAC GRP is 0.04 (i.e., Significant diversification). The correlation of Dermapharm Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Dermapharm Holding Correlation With Market
Good diversification
The correlation between Dermapharm Holding SE and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermapharm Holding SE and DJI in the same portfolio, assuming nothing else is changed.
Dermapharm |
The ability to find closely correlated positions to Dermapharm Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermapharm Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermapharm Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermapharm Holding SE to buy it.
Moving together with Dermapharm Stock
| 0.63 | R2WA | BEXIMCO PHARMAGDR REGS | PairCorr |
| 0.79 | 3IB | PT Indo Tambangraya | PairCorr |
| 0.79 | TL0 | Tesla Inc | PairCorr |
| 0.64 | MAQ | Marriott International | PairCorr |
| 0.81 | 1DH | Clarkson PLC | PairCorr |
| 0.78 | 6GAA | Grupo Aval Acciones | PairCorr |
| 0.72 | 51KB | AVITA Medical | PairCorr |
| 0.64 | HI91 | Hilton Worldwide Holdings | PairCorr |
| 0.77 | ENR | Siemens Energy AG | PairCorr |
| 0.71 | GKD | Grand Canyon Education | PairCorr |
| 0.68 | H0O | REVO INSURANCE SPA | PairCorr |
Moving against Dermapharm Stock
| 0.76 | HX1A | HEXINDO ADIPERKASA | PairCorr |
| 0.76 | KM6 | ADHI KARYA | PairCorr |
| 0.75 | MRK | Merck KGaA | PairCorr |
| 0.6 | I41 | INDIKA ENERGY | PairCorr |
| 0.47 | HX1A | HEXINDO ADIPERKASA | PairCorr |
| 0.55 | DFXN | SIERRA METALS | PairCorr |
| 0.32 | NOAA | Nokia | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Dermapharm Stock performing well and Dermapharm Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermapharm Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 1.04 | (0.19) | 0.00 | (0.58) | 0.00 | 2.08 | 10.92 | |||
| H6D | 1.28 | (0.01) | (0.02) | (0.47) | 1.49 | 2.84 | 8.17 | |||
| LP6 | 1.68 | 0.32 | 0.09 | (5.84) | 2.31 | 5.59 | 20.56 | |||
| S2P | 2.07 | 0.26 | 0.07 | 37.74 | 2.48 | 5.13 | 18.98 | |||
| CJH | 3.59 | 0.73 | 0.15 | 1.27 | 3.56 | 13.07 | 30.83 | |||
| EVT | 3.86 | 0.77 | 0.12 | (0.51) | 4.65 | 9.76 | 36.91 | |||
| DMP | 1.37 | 0.19 | 0.10 | (10.61) | 1.31 | 3.97 | 10.99 | |||
| BSFA | 1.56 | (0.09) | 0.00 | (0.04) | 0.00 | 3.41 | 9.18 | |||
| R2WA | 2.76 | 1.03 | 0.18 | 35.14 | 2.28 | 6.45 | 32.13 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Dermapharm Holding without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Dermapharm Holding Corporate Management
Elected by the shareholders, the Dermapharm Holding's board of directors comprises two types of representatives: Dermapharm Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dermapharm. The board's role is to monitor Dermapharm Holding's management team and ensure that shareholders' interests are well served. Dermapharm Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dermapharm Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Britta Hamberger | Head Communications | Profile | |
| HansGeorge Feldmeier | CEO Board | Profile | |
| Christof Dreibholz | Chief Officer | Profile | |
| Karin Samusch | Member Officer | Profile | |
| Andreas Eberhorn | Chief Officer | Profile |